Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.

Mirska A, Kułak W, Okurowska-Zawada B, Dmitruk E.

Childs Nerv Syst. 2018 Jul 30. doi: 10.1007/s00381-018-3923-6. [Epub ahead of print]

PMID:
30058050
2.

Seasonal Variations in Cerebral Palsy Births.

Sienkiewicz D, Paszko-Patej G, Okurowska-Zawada B, Kułak W.

Arch Med Res. 2018 Feb;49(2):114-118. doi: 10.1016/j.arcmed.2018.05.001. Epub 2018 May 24.

PMID:
29803546
3.

Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial.

Sienkiewicz D, Kułak W, Okurowska-Zawada B, Paszko-Patej G, Wojtkowski J, Sochoń K, Kalinowska A, Okulczyk K, Sienkiewicz J, McEachern E.

Front Neurol. 2017 Oct 26;8:566. doi: 10.3389/fneur.2017.00566. eCollection 2017.

4.

Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies.

Eljaszewicz A, Sienkiewicz D, Grubczak K, Okurowska-Zawada B, Paszko-Patej G, Miklasz P, Singh P, Radzikowska U, Kulak W, Moniuszko M.

Stem Cells Int. 2016;2016:2650849. doi: 10.1155/2016/2650849. Epub 2015 Dec 6.

5.

Duchenne muscular dystrophy: current cell therapies.

Sienkiewicz D, Kulak W, Okurowska-Zawada B, Paszko-Patej G, Kawnik K.

Ther Adv Neurol Disord. 2015 Jul;8(4):166-77. doi: 10.1177/1756285615586123. Review.

6.

Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.

Mirska A, Cybula K, Okurowska-Zawada B, Kułak W, Dmitruk E, Okulczyk K, Kalinowska AK.

J Pediatr Orthop B. 2014 Nov;23(6):517-22. doi: 10.1097/BPB.0000000000000098.

PMID:
25171568
7.

Potential beneficial effects of granulocyte colony-stimulating factor therapy for spastic paraparesis in a patient with kyphoscoliosis: a case report.

Sienkiewicz D, Kułak W, Okurowska-Zawada B, Wojtkowski J, Paszko-Patej G, Dmitruk E, Kalinowska A, Okulczyk K.

Neuropediatrics. 2014 Oct;45(5):325-7. doi: 10.1055/s-0034-1374734. Epub 2014 Apr 21.

PMID:
24752769
8.

Recombinant granulocyte colony-stimulating factor increases muscle strength in neuromuscular disorders.

Kułak W, Sienkiewicz D, Okurowska-Zawada B, Paszko-Patej G, Zak J, Dmitruk E, Wojtkowski J, Okulczyk K, Kaliniowska A, Pogorzelski R.

Pediatr Neurol. 2014 Mar;50(3):e9. doi: 10.1016/j.pediatrneurol.2013.11.016. Epub 2013 Dec 4. No abstract available.

PMID:
24530153
9.

Serum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele.

Okurowska-Zawada B, Kozerska A, Żelazowska B, Kułak W, Wasilewska A, Wysocka J.

Neuropediatrics. 2012 Dec;43(6):314-9. doi: 10.1055/s-0032-1327126. Epub 2012 Sep 24.

PMID:
23007794
10.

[Analysis of quality of life in patiens with low back pain after receiving transcutaneous electrical nerve stimulation (TENS)].

Zaniewska R, Okurowska-Zawada B, Kułak W, Domian K.

Med Pr. 2012;63(3):295-302. Polish.

PMID:
22880451
11.

Quality of life in children and adolescents with cerebral palsy and myelomeningocele.

Okurowska-Zawada B, Kułak W, Otapowicz D, Sienkiewicz D, Paszko-Patej G, Wojtkowski J.

Pediatr Neurol. 2011 Sep;45(3):163-8. doi: 10.1016/j.pediatrneurol.2011.04.006.

PMID:
21824563
12.

Schizencephaly as a cause of spastic cerebral palsy.

Kułak W, Okurowska-Zawada B, Gościk E, Sienkiewicz D, Paszko-Patej G, Kubas B.

Adv Med Sci. 2011;56(1):64-70. doi: 10.2478/v10039-011-0006-2.

PMID:
21444273
13.

Dysphagia in children with infantile cerebral palsy.

Otapowicz D, Sobaniec W, Okurowska-Zawada B, Artemowicz B, Sendrowski K, Kułak W, Boćkowski L, Kuzia-Śmigielska J.

Adv Med Sci. 2010;55(2):222-7. doi: 10.2478/v10039-010-0034-3.

PMID:
20934964
14.

Risk factors for cerebral palsy in term birth infants.

Kułak W, Okurowska-Zawada B, Sienkiewicz D, Paszko-Patej G, Krajewska-Kułak E.

Adv Med Sci. 2010;55(2):216-21. doi: 10.2478/v10039-010-0030-7.

PMID:
20688615
15.

Assessment of risk factors for osteoporosis and fractures in children with meningomyelocele.

Okurowska-Zawada B, Konstantynowicz J, Kułak W, Kaczmarski M, Piotrowska-Jastrzebska J, Sienkiewicz D, Paszko-Patej G.

Adv Med Sci. 2009;54(2):247-52. doi: 10.2478/v10039-009-0039-y.

PMID:
19919941
16.

Clinical and neuroimaging profile of congenital brain malformations in children with spastic cerebral palsy.

Kułak W, Sobaniec W, Gościk M, Oleński J, Okurowska-Zawada B.

Adv Med Sci. 2008;53(1):42-8. doi: 10.2478/v10039-008-0006-z.

PMID:
18467267
17.

Clinical-electroencephalographic analysis of brain bioelectrical activity in children with myelomeningocele and internal hydrocephalus.

Okurowska-Zawada B, Sobaniec W, Kułak W, Smigielska-Kuzia J, Paszko-Patej G, Sienkiewicz D, Sendrowski K.

Adv Med Sci. 2007;52 Suppl 1:200-3.

PMID:
18229665
18.

Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.

Boćkowski L, Okurowska-Zawada B, Sobaniec W, Kułak W, Sendrowski K.

Adv Med Sci. 2007;52 Suppl 1:171-5.

PMID:
18229658
19.

Time of cooing appearance and further development of speech in children with cerebral palsy.

Otapowicz D, Sobaniec W, Kułak W, Okurowska-Zawada B.

Rocz Akad Med Bialymst. 2005;50 Suppl 1:78-81.

PMID:
16119633

Supplemental Content

Loading ...
Support Center